ArcticZymes Technologies - AGM Information 2021

ArcticZymes Technologies ASA: Minutes from Annual General Meeting 2021

(Tromsø 20. May 2021) ArcticZymes Technologies ASA (OSE:AZT) has today, 20. May

held the Annual General Meeting

Please find the minutes attached.

All matters were resolved as proposed in the notice for the Annual General

Meeting.

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.

For further information, please contact:

Børge Sørvoll

CFO

+47 952 90187

About ArcticZymes Technologies ASA

ArcticZymes Technologies is a Norwegian life sciences company focused on the

development, manufacturing and commercialization of novel recombinant enzymes

for use in molecular research, In Vitro Diagnostics (IVD) and therapeutics.

Listed on the Oslo Stock Exchange since 2005 originally under the [Biotec]

ticker, as Biotec Pharmacon. The company rebranded as ArcticZymes Technologies

in 2020 under the [AZT] ticker. Its headquarters are based in Tromsø, Norway, at

the SIVA Innovation Centre. ArcticZymes Technologies' IP and capabilities are

protected via a large portfolio of patents. For more information, please visit

the website: www.arcticzymes.com.

AI assistant